Co-expression of 9-O-acetylated sialoglycoproteins and their binding proteins on lymphoblasts of childhood acute lymphoblastic leukemia: An anti-apoptotic role

Biological Chemistry

Volumn 390, Issue 4, 2009, Pages 325-335

  Mukherjee, Kankana ^a   Chava, Anil K ^a,c   Bandyopadhyay, Suman ^a,d   Mallick, Asish ^a   Chandra, Sarmila ^b   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Kothari Medical Centre   (India)

^c NORTHERN KENTUCKY UNIVERSITY   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Achatinin H; Apoptosis; Bcl 2 Bax proteins; Physiological ligands; Survival

Indexed keywords

9 O ACETYLATED SIALOGLYCOPROTEIN DERIVATIVE; BINDING PROTEIN; SIALOGLYCOPROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOBLAST; MALE; MYELOID LEUKEMIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLATION; ADOLESCENT; ADULT; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; LYMPHOCYTES; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN BINDING; SIALOGLYCOPROTEINS; YOUNG ADULT;

EID: 64849091205     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.036     Document Type: Article

References (44)

1. Aldinucci, D., Poletto, D., Nanni, P., Degan, M., Rupolo, M., Pinto, A., and Gattei, V. (2002). CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts. Exp. Hematol. 30, 1283-1292.
2. Angata, T. and Varki, A. (2002). Chemical diversity in the sialic acids and related α-keto acids: an evolutionary perspective. Chem. Rev. 102, 439-469.
3. Bandyopadhyaya, S., Mukherjee, K., Chatterjee, M., Bhattacharya, D.K., and Mandal, C. (2005). Detection of immune-complexed 9-O-acetylated sialoglycoconjugates in the sera of patients with pediatric acute lymphoblastic leukemia. J. Immunol. Methods 297, 13-26.
4. Brady, H.J.M., Salomons, G.S., Bobeldijk, R.C., and Berns, A.J.M. (1996). T cells from bax α transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. EMBO J. 15, 1221-1230.
5. Cecco, L., Bond, H.M., Bonelli, P., Tuccillo, F., Cerra, M., Tassone, P., Sorice, R., Lamberti, A., Morrone, G., and Venuta, S. (1998). Purification and characterization of a human sialoglycoprotein antigen expressed in immature thymocytes and fetal tissues. Tissue Antigens 51, 528-535.
6. Chatterjee, M., Sharma, V., Mandal, C., Sundar, S., and Sen, S. (1998). Identification of antibodies directed against O-acetylated sialic acids in visceral leishmaniasis: its diagnostic and prognostic role. Glycoconj. J. 15, 1141-1147.
7. Chowdhury, S., Bandyopadhyay, S., Chandra, S., and Mandal, C. (2007). Comparative analysis of differential expression of sialic acids and adhesion molecules on mononuclear cells of bone marrow and peripheral blood in childhood acute lymphoblastic leukaemia at diagnosis and clinical remission. Indian J. Biochem. Biophys. 44, 357-365.
8. Chowdhury, S., Bandyopadhyay, S., Mandal, C., Chandra, S., and Mandal, C. (2008). Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study. BMC Cancer 8, 40.
9. Coligan, E.J., Kruisbeek, M.A., Margulies, H.D., Shevach M.E., and Strober, W. (1993). Current Protocols in Immunology (New York, USA: National Institute of Health), 1, 5.3.2-5.3.4.
10. Ghosh, S., Bandyopadhyay, S., Pal, S., Das, B., Bhattacharya, D.K., and Mandal, C. (2005a). Increased interferon-γ production by peripheral blood mononuclear cells in response to stimulation of overexpressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukaemia. Br. J. Haematol. 128, 35-41.
11. Ghosh, S., Bandyopadhyay, S., Mallick, A., Pal, S., Vlasak, R., Bhattacharya, D.K., and Mandal, C. (2005b). Interferon-γ promotes survival of lymphoblasts overexpressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia (ALL). J. Cell. Biochem. 95, 206-216.
12. Ghosh, S., Bandyopadhyay, S., Mukherjee, K., Mallick, A., Pal, S., Mandal, C., Bhattacharya, D.K., and Mandal, C. (2007). O-acetylation of sialic acids is required for the survival of lymphoblasts in childhood acute lymphoblastic leukemia (ALL). Glycoconj. J. 24, 17-24.
13. Hogarth, L.A. and Hall, A.G. (1999). Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Blood 93, 2671-2678.
14. Hunter, W.M. (1978). In: Handbook of Experimental Medicine, Vol. 14, D.M. Weir, ed. (Oxford, UK: Blackwell Scientific), pp. 1-3.
15. Imadome, K.I., Shimizu, N., Arai, A., Miura, O., Watanabe, K., Nakamura, H., Nonoyama, S., Yamamoto, K., and Fujiwara, S. (2005). Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival. J. Infect. Dis. 192, 1340-1348.
16. Jayadev, S., Liu, B., Bielawska, A.E., Lee, J.Y., Nazaire, F., Pushkareva, M., Yu, M., Obeid, L.M., and Hannun, Y.A. (1995). Role for ceramide in cell cycle arrest. J. Biol. Chem. 270, 2047-2052.
17. Kelm, S. and Schauer, R. (1997). Sialic acids in molecular and cellular interactions. Int. Rev. Cytol. 175, 137-240.
18. Klein, A. and Roussel, P. (1998). O-acetylation of sialic acids. Biochimie 80, 49-57.
19. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
20. Lowry, O.H., Rosebrough, N.J., Farra, A.L., and Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
21. Mandal, C., Basu, S., and Mandal, C. (1989). Physicochemical studies on Achatinin-H, a novel sialic acid binding lectin. Biochem. J. 257, 65-71.
22. Mandal, C., Chatterjee, M., and Sinha, D. (2000). Investigation of 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia. Br. J. Haematol. 110, 801-812.
23. Nauseef, W.M., Root, R.K., and Malech, H.L. (1983). Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J. Clin. Invest. 71, 1297-1307.
24. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
25. Pal, S., Chatterjee, M., Bhattacharyya, D.K., Bandhyopadhyay, S., and Mandal, C. (2000). Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia. Glycobiology 10, 539-549.
26. Pal, S., Ghosh, S., Bandyopadhyay, S., Mandal, C., Bandhyopadhyay, S., Bhattacharya, D., and Mandal, C. (2004a). Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukemia. Int. J. Cancer 111, 270-277.
27. Pal, S., Ghosh, S., Mandal, C., Kohla, G., Brossmer, R., Isecke, R., Merling, A., Schauer, R., Schwartz-Albiez, R., Bhattacharya, D.K., and Mandal, C. (2004b). Purification and characterisation of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukaemia. Glycobiology 14, 859-870.
28. Pal, S., Bandhyopadhyay, S., Chatterjee, M., Hall, A.G., Bhattacharya, D.K., and Mandal, C. (2004c). Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia. Clin. Biochem. 37, 395-403.
29. Reuter, G., Pfeil, R., Stoll, S., Schauer, R., Kamerling, J.P., Versluis, C., and Vliegenthart, J.F.G. (1983). Identification of new sialic acids derived from glycoprotein of bovine submandibular gland. Eur. J. Biochem. 134, 139-143.
30. Romano, M.F., Lamberti, A., Tassone, P., Alfinito, F., Costantini, S., Chiurazzi, F., Defrance, T., Bonelli, P., Tuccillo, F., Turco, M.C., et al. (1998). Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 92, 990-995.
31. Salomons, G.S., Brady, H.J., Verwijs-Janssen, M., Van Den Berg, J.D., Hart, A.A., Van Den Berg, H., Behrendt, H., Hahlen, K., and Smets, L.A. (1997). The Bax α:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int. J. Cancer 71, 959-965.
32. Schauer, R. (2000). Achievements and challenges of sialic acid research. Glycoconj. J. 17, 485-499.
33. Schauer, R. (2004). Sialic acids: fascinating sugars in higher animals and man. Zoology 107, 49-64.
34. Sen, G. and Mandal, C. (1995). The specificity of the binding site of Achatinin-H α sialic-acid binding lectin from Achatina fulica. Carbohydr. Res. 268, 115-125.
35. H, a 9-O-acetylated sialic acid binding lectin. Am. J. Trop. Med. Hyg. 58, 551-554.
36. Sinha, D., Mandal, C., and Bhattacharya, D.K. (1999a). Identification of 9-O-acetyl sialoglycoconjugates (9-O-AcSGPs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, Achatinin H, as a probe. Leukemia 13, 119-125.
37. Sinha, D., Mandal, C., and Bhattacharya, D.K. (1999b). Development of a simple, blood based lymphoproliferation assay to assess the clinical status of patients with acute lymphoblastic leukaemia. Leuk. Res. 23, 433-439.
38. Sinha, D., Bhattacharya, D.K., Mandal, C. (1999c). A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukemia (ALL) employing achatinin H: a 9-O-acetyl sialic acid binding lectin. Leuk. Res. 23, 803-809.
39. Sinha, D., Mandal, C., and Bhattacharya, D.K. (1999d). A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia. Leukemia 13, 309-312.
40. Srinivas, G., Kusumakumary, P., Nair, M.K., Panicker, K.R., and Pillai, M.R. (2000). Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia. J. Cancer Res. Clin. Oncol. 12, 662-667.
41. Voorzanger-Rousselot, N. and Blay, J.Y. (2004). Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role. Leuk. Lymphoma 45, 1239-1245.
42. Voorzanger-Rousselot, N., Favrot, M.C., and Blay, J.Y. (1998). Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells. Blood 92, 3381-3387.
43. Voorzanger-Rousselot, N., Alberti, L., and Blay, J.Y. (2006). CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways. BMC Cancer 18, 75.
44. Yin, X.-M., Oltvai, Z.N., and Korsmeyer, S.J. (1994). BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321-323.